Yu-jin Xu

发表

Positive expression of p53, c-erbB2 and MRP proteins is correlated with survival rates of NSCLC patients.

Liancong Wang, Yu-jin Xu, Yuezhen Wang, 2013, Molecular and clinical oncology.

Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer

Yamei Chen, C. Gay, Yuhua Gong, 2021, Clinical Cancer Research.

Automatic segmentation of cardiac substructures from noncontrast CT images: accurate enough for dosimetric analysis?

Daniel Gomez, Zhongxing Liao, Laurence E Court, 2018, Acta oncologica.

A phase III multicenter randomized clinical trial of 60 Gy vs 50 Gy radiation dose in concurrent chemoradiotherapy for inoperable esophageal squamous cell carcinoma.

Z. Liao, Zongwen Sun, Jiong Cai, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Clinical and Dosimetric Factors Predicting Grade ≥2 Radiation Pneumonitis After Postoperative Radiotherapy for Patients With Non-Small Cell Lung Carcinoma.

R. Mohan, D. Gomez, R. Komaki, 2018, International journal of radiation oncology, biology, physics.

A combined predictive model based on radiomics features and clinical factors for disease progression in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy

G. Shao, Ming Chen, You-hua Jiang, 2022, Frontiers in Oncology.

Final report of a prospective randomized study on thoracic radiotherapy target volume for limited-stage small cell lung cancer with radiation dosimetric analyses—reply

Ming Chen, Xiao-ling Xu, You-hua Jiang, 2019, Cancer.

Dosimetric comparison of the helical tomotherapy, volumetric-modulated arc therapy and fixed-field intensity-modulated radiotherapy for stage IIB-IIIB non-small cell lung cancer

Z. Liao, Ming Chen, W. Deng, 2017, Scientific Reports.

Association between clinicopathological factors and postoperative radiotherapy in patients with completely resected pathological N2 non-small cell lung cancer.

Ming Chen, Yu-jin Xu, Xiao Zheng, 2017, Oncology letters.

Derived Neutrophil-Lymphocyte Ratio and C-Reactive Protein as Prognostic Factors for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy

Ming Chen, Xuan Zhu, Yu-jin Xu, 2023, Diagnostics.

Survival Patterns for Patients with Resected N2 Non–Small Cell Lung Cancer and Postoperative Radiotherapy: A Prognostic Scoring Model and Heat Map Approach

Z. Liao, Pei Yang, Ting Xu, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Log odds of positive lymph nodes may predict survival benefit in patients with node-positive non-small cell lung cancer.

Z. Liao, Pei Yang, W. Deng, 2018, Lung cancer.

Choice of immobilization of stereotactic body radiotherapy in lung tumor patient by BMI

Ming Chen, Wei Xu, G. Shan, 2019, BMC Cancer.

Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in Chinese population: A retrospective study

Ming Chen, X. Bai, Yu-jin Xu, 2017, Oncotarget.

HELPER study: A phase II trial of continuous infusion of endostar combined with concurrent etoposide plus cisplatin and radiotherapy for treatment of unresectable stage III non-small-cell lung cancer.

Lujun Zhao, Jun Liang, Ming Chen, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Comparison of the outcomes of stereotactic body radiotherapy versus surgical treatment for elderly (≥70) patients with early-stage non-small cell lung cancer after propensity score matching

Ming Chen, Xuan Zhu, Jianping Cao, 2019, Radiation Oncology.

Comparison of stereotactic body radiation therapy versus surgery for multiple primary lung cancers after prior radical resection: A multicenter retrospective study

Hui Jiang, Xuan Zhu, Runzhe Chen, 2023, Clinical and translational radiation oncology.

The impact of prophylactic cranial irradiation for post-operative patients with limited stage small cell lung cancer

Ming Chen, Yu-jin Xu, Xiao Hu, 2018, Medicine.

Treatment of lung recurrence after radical resection of non-small cell lung cancer: a single-center retrospective analysis using body stereotactic radiotherapy vs. reoperation

Yu-jin Xu, Qingshan Wu, B. Dong, 2021 .

Timing of thoracic radiotherapy is more important than dose intensification in patients with limited-stage small cell lung cancer: a parallel comparison of two prospective studies

Ming Chen, Yu-jin Xu, X. Fu, 2019, Strahlentherapie und Onkologie.

Prognostic performance of inflammation-based prognostic indices in locally advanced non-small-lung cancer treated with endostar and concurrent chemoradiotherapy.

Ming Chen, Yu-jin Xu, F. Peng, 2016, Molecular and clinical oncology.

Whole-tumor perfusion CT using texture analysis in unresectable stage IIIA/B non-small cell lung cancer treated with recombinant human endostatin.

Xu Wang, Ming Chen, P. Pang, 2019, Quantitative imaging in medicine and surgery.

Predictive Value of Nutritional Risk Screening 2002 and Prognostic Nutritional Index for Esophageal Cancer Patients Undergoing Definitive Radiochemotherapy

Ming Chen, Yu-jin Xu, Yuanyuan Chen, 2018, Nutrition and cancer.

A study of the prognosis of patients with limited-stage small cell lung cancer who did or did not receive prophylactic cranial irradiation after effective chemoradiotherapy

Ming Chen, Yu-jin Xu, Qun Zhang, 2023, Frontiers in Oncology.

Efficacy of Concurrent Chemoradiotherapy With S-1 vs Radiotherapy Alone for Older Patients With Esophageal Cancer: A Multicenter Randomized Phase 3 Clinical Trial.

Jun Ma, K. Xie, Ming Chen, 2021, JAMA oncology.